Abstract:Background: Conventional cytogenetics only analyzes metaphase cells and this analysis is affected by chromosome number and quality. A large mass of metaphase or interphase cells can be detected by fluorescence in situ hybridization on chromatosome and bone marrow smears to examine the number and structure of chromatosome. Objective: To test chromosome abnormality by fluorescence in situ hybridization and compare with the results from conventional cytogenetic analysis (CCA) in myelodysplastic syndrome (MDS). Design, Time and Setting: A case analysis was conducted at the Shenzhen Hospital of Peking University from August 2006 to September 2007. Participants: Forty-eight MDS patients, who had been preliminarily diagnosed according to FAB criteria, followed up and received chromatosome examination, were enrolled at the Shenzhen Hospital of Peking University. Simultaneously, five iron deficiency anemia patients were included as controls. Bicolor probe and CEP8 SpectumAqua probe were purchased from Vysis. Methods: Bone marrow samples received CCA by R differential staining technique. Slide was prepared by direct or short-term culture method, at least 20 karyotypes in each sample. Remaining samples received fluorescence in situ hybridization. Using airdrying, fluid was prepared at the ratio of 1:2:7 (probe: water: hybrid buffer solution), dropped in the hybrid region of the slide. Red/green fluorescence hybrid signal of interphase cells were observed under a fluorescent microscope and color filter glass, 200 in each sample. Main Outcome Measures: Abnormal positive rate of bone marrow cells was measured by two techniques. Results: Of 48 MDS patients, 38 survived after 24 months of follow-up. Using CCA, karyotype abnormalities were found in 18 (37.5%) of 48 cases, among which complex karyotypes were found in 4 (8.3%) cases, a deletion of chromosome 5/a deletion of the long arm of chromosome 5 (-5/5q-) in 5 (10.4%) cases, -7/7q- in 5 (10.4%) cases, trisomy 8 in 8 (16.6%) cases, 20q- in 2 (4.6%) cases, unconsistent translocations in 3 (6.2%) cases. Fluorescence in situ hybridization detected 5q- in 2 additional cases, 7q- in 5 additional cases, -7 in 1 additional case, +8 in 12 addition cases in addition to confirming -5/5q-, -7/7q- and +8 found by CCA in 5, 5, 8 cases raising the detection rates of -5/5q-, -7nq- and +8 to 14.5%, 22.9% and 41.7%, respectively. Conclusion: The fluorescence in situ hybridization with panel probes is more sensitive and specific for detection of chromosome 5, 7, 8 abnormalities in MDS patients than that of CCA. But it cannot replace CCA, because it cannot detect the chromosome translocation. This indicates that their combination can increase the positive rate of chromosome abnormality in MDS patients.

Detection of chromosome number abnormalities in lung cancer by fluorescence in situ hybridization

[The Application of Dual-Color Fluorescence in Situ Hybridization to the Diagnosis of Klinefelter Syndrome].

Progress in the application of FISH for the molecular characterization of lymphomas

[Detection of genomic abnormalities among 105 patients with chronic lymphocytic leukemia using fluorescence in situ hybridization].

Chromosome aberration of urine exfoliated cells to diagnose bladder neoplasm by fluorescence in situ hybridization

Clinical Application of Multicolor Fluorescence in Situ Hybridization on Early Diagnosis of Lung Cancer

[Study on Clinical Features and Fluorescence in Situ Hybridization Detections of 22q11 Microdeletion Syndrome].

Genomic Alterations in Lung Adenocarcinomas Detected by Multicolor Fluorescence in Situ Hybridization and Comparative Genomic Hybridization

Multicolor Fluorescence in Situ Hybridization and Comparative Genomic Hybridization Reveals Molecular Events in Lung Adenocarcinomas and Squamous Cell Lung Carcinomas

[Fluorescence in Situ Hybridization Combined with Cytomorphology for the Detection of Lung Cancer in Bronchial Brushing Specimens].

Detecting the abnormity of chromosomes 8 and 20 aberrations in myelodysplastic syndromes by using fluorescence in situ hybridization

Identification Of Genetic Mutations In Human Lung Cancer By Targeted Sequencing

Simultaneous in Situ Detection of Protein Expression of Multiple Tumor Markers of Circulating Tumor Cells and Heteroploid of Chromosome 8 in Primary Lung Cancer

Identification of complex chromosome abnormalities in esophageal carcinoma cells KYSE450 by multicolor fluorescence in situ hybridization

Application of Multicolor Fluorescence in Situ Hybridization to Early Diagnosis of Esophageal Squamous Cell Carcinoma

Chromosomes 5, 7 and 8 abnormalities in myelodysplastic syndromes by using interphase fluorescence in situ hybridization

Detection of Chromosomes 5 and 7 Aberrations in Myelodysplastic Syndromes Using Dual-Color Fluorescence in Situ Hybridization

Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in China.

[Detection of Chromosomal Aberration in Sporadic Colorectal Cancer with Comparative Genomic Hybridization].

Analysis of Deletion of 3p and 9p in Human Lung Cancer

Application of fluorescence in situ hybridization in the diagnosis of solid tumors